Ultratag

   
Google
 
Web NewDrugInformation.com

Ultratag


Drug - Ultratag
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Technetium Tc-99m Red Blood Cell Kit
Multiple ingredients are in alphabetical order.

Strength - N/A
The potency of the active ingredient(s), Technetium Tc-99m Red Blood Cell Kit. May repeat for multiple part products.

Applicant - MALLINCKRODT
The firm name holding legal responsibility for Ultratag. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019981
The FDA assigned number to Ultratag. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Ultratag. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 10, 1991
The date Ultratag was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Ultratag. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ultratag is in. Format is RX, OTC, DISCN.

Applicant Full Name - Mallinckrodt Medical Inc
The full name of the firm holding legal responsibility for the new application of Ultratag.

Ultratag